Efficacy and Safety of Vamifeport in Adult Participants With Homeostatic Iron Regulator Gene (HFE)-Related Hereditary Hemochromatosis
Clinical trial NCT07332091 · RECRUITING
Trial details
- NCT number
- NCT07332091
- Sponsor
- CSL Behring
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2026-01-22
- Primary completion
- 2028-03-06
- Enrollment
- 84
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.